chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided. Patient did not experience any other adverse reactions.   This case was linked to MOD-2021-395985 (Patient Link).
Devel hives on face & trunk; about 6 hrs p/immun; more hives in AM 26MAR; phone call to hlth cent 26MAR about 830AM; referred to MD;
2 days after receiving Pfizer vaccine in my right arm, my armpit and lymph nodes swelled and hurt twice the size of my other arm.
Go the medicine for vomiting 12/14/2021 from physician. 12/17/2021 called out sick from work. Really began to fill unwell on 12/18/2021 drove to hospital admitted was given Dexamethasone 6mg, given shot to prevent blood clots, and put on an inhaler albuterol, and rubatosis.   2nd Dose doctor c positive on 11/-18/2021 nurse said wait 90 on the 17th of Nov. I went to the hospital. Nov. 18 to Nov. 20 afternoon hospitalized 5:30 PM discharged by doctor. Tested days that if you are not mandated since Jan. Hospitalization to second. Doctor gave a note that will allow two weeks to miss work and send to employer. Still have a cough and no sense of taste and cough is dry.
Patient reports symptoms starting about 2 days after vaccine.  Left arm/shoulder feels like it was hit by a sledgehammer with numbness throughout arm and hand.  He cannot move his wrist and has limit range of motion for his elbow and shoulder.
Starting the night of receiving the vaccine, I developed a warm sensation all over my body. The next day I went to work and I had to keep drinking fluids but I couldn't get rid of that warm feeling. This lasted for a couple days then resolved its own. This past Monday (05/02/2022) I developed another shingles episode less than a month from receiving my last booster dose. I have been having episodes since my gastric sleeve surgery (2018) but its been awhile since I have had one. It always pops up on the left arm, which happens to be the same arm I got the vaccine in.
This case was reported by a healthcare professional and described the occurrence of a 30-year-old female subject not responding to therapy following vaccination with hepatitis B  vaccine recombinant for prophylaxis. The subject was allergic to codeine and prochlorperazine (Compazine). There were no concomitant medications. On unspecified dates the subject received 3rd dose, 2nd dose and 1st dose of Hepatitis B vaccine. This completed a three dose series for hepatitis B. The dose, lot number and expiration dates for each administration were not provided. On a date on or before 24 July 2006, the subject, a nursing student, received a "surface antibody test" to do clinicals and the reading was 8.7. The subject was considered a non-responder and was not allowed by her school to participate in clinicals. Documentation received noted that the actual trade name of the Hepatitis B vaccine administered was not known. Manufacturer was notified in case the subject received Engerix-B. Follow-up regarding this case was received on 29 September 2006. On 24 July 2006, a hepatitis B surface antibody was 8.7 MIU/ml. On 07 September 2006, a hepatitis B surface antibody was negative. The reporting healthcare professional considered the event to be possibly related to vaccination with hepatitis B vaccine. At the time of reporting, the outcome was unknown.
About 4 hours after the vaccine patient stated she felt funny and was feeling cold but also warm, shivery, sweaty, dizzy.  Other stated her face went white and then she was covered in hives.  She was given Benadryl, prednisone, and Vistaril for treatment and monitored to be sure she did not come down with more severe symptoms.  She has never reacted to a vaccine in the past and states she has never reacted to eggs before either.
30 minutes after eating I start having the sensation of pins & needles followed by numbness that begins in my neck, goes to my ear and then spreads to the rest of my face; 30 minutes after eating I start having the sensation of pins and needles; This is a spontaneous report from a contactable consumer (patient). A 28-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 1  at vaccination age of 28-year-old via an unspecified route of administration in the left arm on Apr2021 12:45 PM (Lot Number: ER8731) as 1st dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with Covid-19 prior to vaccination. The patient has no known allergies. The patient did not receive other vaccine in four weeks. It was reported that 30 minutes after eating (01May2021 13:00), she start having the sensation of pins and needles followed by numbness that begins in her neck that goes to her ear and then spreads to the rest of her face. It can happen on either side of her face or throughout her entire face. She took an allergy test on 2021 thinking it was food related and have no allergies. There is no clear pattern of which foods trigger it. It does not occur with every meal. If she take Benadryl the effects will go away within an hour or two and If she does not take any medication the affects will last for about 4-6 hours. This has happened to her about 6 times within the span of 3 weeks. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received treatment which included Benadryl. The patient has not been covid tested post vaccination. The outcome of the events was unknown.
Arm was red; Very low grade fever; Arm pain/Arm was sore and tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain/Arm was sore and tender), VACCINATION SITE ERYTHEMA (Arm was red) and PYREXIA (Very low grade fever) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm pain/Arm was sore and tender) and PYREXIA (Very low grade fever). On 10-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm was red). On 04-Jan-2021, VACCINATION SITE PAIN (Arm pain/Arm was sore and tender) and PYREXIA (Very low grade fever) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Initial report received on 13Jul06 from another manf who had originally received the report from a healthcare professional. A 69 yr old female pt with a past medical history of allergy to Penicillin (hives), and who had a current work related injury of left leg contusion with probable hematoma, had received an intra muscular dose of Fluzone 2005-2006, lot number U1912AA and a first IM dose of Pneumovax 23, lot number 650649/0790P, on 07Nov05 at 16:30PM. The sites of administration were not reported for either vaccine administered. At 22:00PM, five hours post immunization, the pt developed left upper arm erythema with mild to moderate warmth. Her arm was tender and swollen from the shoulder down with a beefy rash. The pt received unspecified medical attention and was diagnosed with questionable cellulitis. She was treated with Tylenol, antibiotics (Keter), and prednisone. The pt subsequently recovered from these adverse events. Per the reporter, the cellulitis was considered to be an important medical event (OMIC).
Positive COVID test on 7/10/21. Symptoms started on 7/7/21. Benign start to symptoms with sore throat, cough, congestion. Progressed to fatigue, malaise, anorexia, loss of taste and smell, tachycardia with ambulation.
pt recv vax 12JUL94 & 13JUL94 pt exp general malaise & nausea; 14JUL94 pt felt tired; 15JUL94 pt devel stomach aches; 16JUL94 devel a high fever of 104 & presented to ER; MD felt fever was due to rxn from vax
Exfoliative skin rash, most likely PRP (pityriasis rubra pilaris) - symptoms started 2 weeks after 2nd moderna dose (4/3)
Pain, redness, and blisters at vaccination site.  Patient went to the ER twice and treated for allergic reaction and cellulitis.  Patient still with residual open wound of L upper arm.
hearing loss; upper respiratory lungs; fatigue; asthma since Apr shot; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration on 02Apr2021, as dose 2, single for COVID-19 immunisation. Medical history included COVID-19 on 27Feb2020 and 14Apr2020 (no testing yet, so unverified). The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On an unspecified date in Apr2021, the patient experienced hearing loss, upper respiratory lungs, fatigue and asthma since April shot. The patient underwent lab tests and procedures which included computerised tomogram: cat got upper respiratory on Apr2021, computerised tomogram: cat shows shriveled air sacs on an unspecified date in 2021. All symptoms including that of lungs resolved over summer, at home. All were normal except asthma since April shot (hearing loss from original infection). In August, the patient steroids for both, lungs and energy was better. Therapeutic measures were taken as a result of the events. The outcome of the events hearing loss; asthma since April shot was not resolved. The outcome of events upper respiratory lungs; and fatigue was resolved on unspecified dates in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient Reports "tongue swelling but no breathing difficulty". Patient states she went to the Emergency Room the evening of her Flu shot and they gave her Benadryl.
Pain redness swelling L thigh 24 hrs post injection.  No meds was already on antibiotics for sinusitis (Zithromax) no change made.
He was admitted to the hospital due to one week of cough, SOB and diarrhea on 9/13/21. He stated he was recently exposed to his sister who is now hospitalized with COVID. On hospital day 3, his O2 sat is 98% on room air, and he is not febrile.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: 5 minutes post vaccination, pt's husband stated that the pt wasn't feeling well.  She complained of being dizzy and not being able to breathe.  911 was called at this point.  Put pulse ox on her finger and her O2% never went below 98 during the entire episode.  We laid pt on the floor and we were prepared to give an EpiPen if needed. EMS arrived, she stated she was feeling a little better.  F/u w/husband at 7pm.  He said she was fine and no treatment was given at hospital. No allergic reaction.
I have been sick every day with fever, heavy chest pains, like a brick on my chest, shivering, muscles aches and itchy skin and eyes?
Injection site pain  Fever Chills Tiredness/weakness Body aches muscle/joint pain Nausea Feeling unwell Headache Tingling fingertips
Dtap and HIB given but were also given in October 2021, therefore received an extra dose of each of these on 4/27/22.  No adverse reaction at this time.
This spontaneous report was received from a physician refers to 4 patients of unknown age and gender. On 01-APR-2013 the patients were vaccinated with GARDASIL (lot number H021608, expiration date 13-AUG-2015, route not reported). The physician noted that GARDASIL was shipped on 27-MAR-2013 and did not arrive at the office until 01-APR-2013 and the GARDASIL was in the shipper the entire time. The physician's office could not determine the exact temperature the GARDASIL was exposed to while in the shipment from 27-MAR-2013 to 01-APR-2013. No patient contact details available. No further information was available. Follow up information was received. The receptionist stated that she spoke with the nurse and she was not aware of the situation and she also stated that the physician would call back. Follow up document included information about 18 year old male patient who on 01-APR-2013 (at 13:34) was vaccinated in left arm with a third dose of GARDASIL (lot number H021608, expiration date 13-AUG-2015, route and dose not reported). There was none adverse event. This is one of several reports from the same source. Additional information is not expected.
fatigue, muscle aches, fever 100, chills. symptoms  started the evening after getting the shot and lasted 12 hours. by morning I felt okay
Heart palpitations, including strong, rapid heartbeat. Chest fluttering and sensation of skipped or rapid succession beats with chest tightness. Fluttering sensation will often force a cough out. Strongest day of, and whereas existed over the past five days seems to be strongest on day five. Currently 15 weeks pregnant. First time mom. Estimated due date 10/08/2021.
After administering vaccines patient stated he felt dizzy and started to become pale. Applied a cool compress to back of neck and laid patient down. Patient never lost consciousness. Gave him some water and notified provider. VS taken and WNL Gave him some trail mix and had him sip on water. He stated he started to feel better. Had patient wait in office for 15min and patient was able to stand up and color came back and stated he felt better.
At 2:30 AM on 1/16 about 10 hours after the shot I spiked a 102 fever, dizziness, throwing up, extreme joint pain from my jaw to my ankles, chills, sweats. I also had a huge sac under my armpit on the injection site assuming my lymph node also a swollen neck on the left side. Fever lasted 3 days of 102
This case was reported by a physician via a sales representative and described the occurrence of swelling of arm following injection in a subject aged between 0 and 9 years old ("kindergarten age") of unspecified gender who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. Concurrent vaccination included live attenuated oral poliomyelitis vaccine (manufacturer unspecified) given on the same date as Infanrix. On an unspecified date the subject received unspecified dose of Infanrix (unknown, unknown arm). At the unspecified time after vaccination with Infanrix, the subject experienced swelling of the arm in which the injection was given. The arm swelling extended to the elbow. The physician questioned whether there was a "problem with this lot of Infanrix" due to a similar reaction in a second patient (see GSK reference number A0670229A). Medical attention was required at a doctor's office. At the time of reporting the outcome of the event was unspecified. The physician considered the event was possible related to vaccination with Infanrix.
Information was receved from a field representative who received information from a pharmacist reporting on a male of unknown age received a dose of ZOSTAVAX, vial for prevention of shingles "a few weeks ago"  (lot # and expiration unknown). Concomitant medication and medical history were unknown. The pharmacist reported that the patient reported to her, he developed itchiness at the injection site. It was unknown if treatment was given to the patient. Outcome was unknown. No other information was reported. Additional information has been requested.
pt admitted to hosp 19nov96 w/ dx of GBS. Is currently on the skilled nursing unit.
L shoulder pain following vaccine. EE seen for medical treatment on 1/8. was dx with subacromial bursitis secondary to vaccine placement. ice, rest, medication
Employees arm was hurting really bad. Pain started going up into the shoulder. Employee went to urgent care on 9/29. They said the muscle was swollen but it didn't seem to get better. Employee went to her own physician on 10/4. Physician said it was a reaction to the COVID vaccine she had over a year ago. He prescribed her some meds and she is now feeling better.
HIS FEVER BEGAN THAT EVENING HE WAS GIVEN THE NASAL VACCINE. I GAVE HIM CHILDRENS ADVIL AND IT WORKED. ON THE NIGHT OF 1/14 HIS FEVER GOT UP TO 102.0F AND HE WAS UNABLE TO SLEEP BECAUSE HIS BODY ACHED AND HE WAS SO HOT AND HIS HEART BEATING VERY FAST. I AGAIN GAVE HIM CHILDRENS ADVIL AND AN HOUR LATER HIS FEVER WENT DOWN BUT STILL HOT AND UNABLE TO SLEEP.
Information has been received from a medical assistant who heard from a physician's assistant concerning some patients who were vaccinated with unspecified dose of GARDASIL (lot#, route and site of administration not reported). Subsequently, the patients became blind and paralyzed. At the time of this report, the patient's outcomes were unknown. Upon internal review, blind and paralyzed were considered to be other important medical events. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
Pt reports approx. 7 days post 2nd dose he developed fever of 101 F and chills. Pt reports the took Tylenol 3x q5-6 hours yesterday only, this broke his fever.
Ct. began with inconsolable- high pitched crying approximately 4 hours after immunization. Right thigh where ct. received HIB injection was edematous, red and warm to the touch. Ct. was moving both legs equally. Ct. was transported on to ER by parents.
Chills, fever, body aches, nausea after getting Prevnar 13.
Patient was given 0.25 ml for her second dose of the vaccine series instead of 0.5 ml
Information was received from a pharmacist via a company representative regarding a 58 year old female patient. On an unknown date, the patient was vaccinated at a different pharmacy with ZOSTAVAX, 0.65 ml. Immediately after the injection, the patient experienced an injection site reaction of a hot, burning sensation. The patient also had the "same effect" with an unspecified "TD shot." (see case #1311USA004572). The outcome of the injection site reaction of a hot, burning sensation was reported as recovered. Additional information has been requested.
pt recvd 2nd dose of vax & devel burning sensation upon inject w/soreness &/or an aching sensation in the arm; This sensation persisted assoc w/a feeling of heaviness in the arm which lasted x 24 hrs; pt denied fever, local swelling;
sore at injection site, swollen lymph nodes in left armpit, fatigue, headache starting at 7pm, chills, sweating, & body ache started around 9pm the same day and lasted about 24 hours
booster doses administered after expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient All booster doses were injected intramuscularly in deltoid muscle. No treatment information were reported. No concomitant medications were reported.
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Additional Details: pt stated she went to doctor and he said she she had contracted cellulitis refused to give further details to us
pt was a nursing home pt.  pt received first dose of covid vaccine.  pt was monitored for 15 minutes after getting shot. staff reported that pt was 15 days post covid.  Pt passed away with in 90 minutes of getting vaccine
headache, back pain, vaginal pain, left arm pain, hot flashes, loss of appetite
Had DTaP administered on 10/15/02 L thigh within 48 hours had papular rash starting at site of injection over next 24 hours rash spread to arms/legs/face/abdomen.
Patient with a hx of rheumatoid arthritis who was on active immunosuppressive therapy (specifically, methotrexate, prednisone and Plaquenil) went to an area retail pharmacy and requested and received a varicella zoster vaccine. It was administered by a licensed pharmacist who was certified in vaccine administration. Two weeks later she developed a dermatomal rash low grade fever and mild pain and discomfort in the rash area. Two weeks after the rash onset she began experiencing some left ocular pain, discomfort, and headaches which went on for 2 days. She then developed abrupt onset of decreased vision in that left eye without any other clinical manifestations.  She was seen by her primary ophthalmologist, who made a primary evaluation with possible diagnosis of acute retinal necrosis. She was started on Valtrex 1g TID po on Monday 11/22 and stopped her immunosupression. She was referred to a retinal specialist who admitted her to Hospital. She was seen by Dr. who diagnosed her with acute retinal necrosis secondary to herpes zoster related to recent Zostavax vaccination. I, infectious disease pharmacist, participated in her care in dosing and monitoring of her IV antiviral medications and in reporting of adverse drug events at hospital.